A critical discovery in cancer research is occurring with the use of mini-antibodies to re-engage mutated p53. This vital cancer protector protein is frequently inactivated in various forms of malignancies, resulting https://hylistings.com/story23342285/nanobodies-reactivate-p53-a-promising-approach-for-malignant-therapy